Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
6.07
-0.53 (-8.03%)
At close: Mar 24, 2026, 4:00 PM EDT
6.05
-0.02 (-0.30%)
After-hours: Mar 24, 2026, 6:53 PM EDT
Cartesian Therapeutics Employees
Cartesian Therapeutics had 75 employees as of December 31, 2025. The number of employees increased by 9 or 13.64% compared to the previous year.
Employees
75
Change (1Y)
9
Growth (1Y)
13.64%
Revenue / Employee
$37,293
Profits / Employee
-$1,737,360
Market Cap
160.91M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 75 | 9 | 13.64% | 75 | 0 |
| Dec 31, 2024 | 66 | 28 | 73.68% | 66 | 0 |
| Dec 31, 2023 | 38 | - | - | 37 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Protalix BioTherapeutics | 226 |
| Sutro Biopharma | 178 |
| Cibus | 159 |
| Adagene | 138 |
| Molecular Partners AG | 134 |
| Caribou Biosciences | 97 |
| Whitehawk Therapeutics | 22 |
RNAC News
- 7 weeks ago - Cartesian Therapeutics Announces New Employment Inducement Grants - GlobeNewsWire
- 2 months ago - Cartesian Therapeutics Highlights Recent Progress and Outlines 2026 Outlook - GlobeNewsWire
- 3 months ago - Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors - GlobeNewsWire
- 4 months ago - Cartesian: Maintaining Buy Rating For Expansion Of Descartes-08 For Myositis - Seeking Alpha
- 6 months ago - Cartesian Therapeutics Announces New Employment Inducement Grant - GlobeNewsWire
- 7 months ago - Cartesian Therapeutics, Inc. (RNAC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 7 months ago - Cartesian Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 10 months ago - Cartesian Therapeutics Announces First Participant Enrolled in the Phase 3 AURORA Trial of Descartes-08 in Patients with Myasthenia Gravis - GlobeNewsWire